Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics: Buy Into Future Patient Demand, At An Undervalued Price Today
07:36am, Tuesday, 15'th Jul 2025
For my initial rating of Quest Diagnostics (DGX), I'm calling it a buy. Forecasts point to continuing demand for diagnostic testing, while the company also grew its business via acquisitions and new s
Quest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
08:24am, Wednesday, 09'th Jul 2025
Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J. , July
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?
09:01am, Monday, 07'th Jul 2025
DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
11:10am, Wednesday, 02'nd Jul 2025
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised
Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?
09:51am, Wednesday, 02'nd Jul 2025
DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 27'th Jun 2025
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
10:45am, Thursday, 26'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Releases 2024 Corporate Responsibility Report
09:07am, Wednesday, 25'th Jun 2025
SECAUCUS, N.J. , June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report.
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
10:52am, Monday, 23'rd Jun 2025
SECAUCUS, N.J. , June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial res
DGX Stock Up on New Blood Test Development Deal With MD Anderson
09:40am, Tuesday, 17'th Jun 2025
DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.
Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
08:03am, Tuesday, 10'th Jun 2025
SECAUCUS, N.J. , June 10, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a collaboration with The University of Texas MD An
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
10:46am, Monday, 02'nd Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
09:25am, Tuesday, 27'th May 2025
With women's health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women's he
What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year?
08:50am, Wednesday, 21'st May 2025
DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions.
More Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
08:52am, Tuesday, 20'th May 2025
Quest's second "Know Your Health" survey explores Americans' perceptions and priorities on their well-being in 2025 Nearly one-third of Americans say their doctors/HCPs do not take the time to discuss
